{"SPADE_UN_28005": {"Sequence Information": {"Peptide Name": "Indolicidin [W4,6,8,9,11F]", "Sequence": "ILPFKFPFFPFRR", "Sequence Length": 13, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P33046", "uniprotUrl": "http://www.uniprot.org/uniprot/P33046", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide.", "Pubmed ID": "20196123", "Reference": "J Pept Sci. 2010;16:171-177", "Author": "Ando S, Mitsuyasu K, Soeda Y, Hidaka M, Ito Y, Matsubara K, Shindo M, Uchida Y, Aoyagi H", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/20196123"}, {"Title": "Structure-function relationships in the tryptophan-rich, antimicrobial peptide indolicidin.", "Pubmed ID": "11695650", "Reference": "J Pept Sci. 2001;7:552-564", "Author": "Staubitz P, Peschel A, Nieuwenhuizen WF, Otto M, Götz F, Jung G, Jack RW", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/11695650"}, {"Title": "Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.", "Pubmed ID": "19576903", "Reference": "J Mol Biol. 2009;392:837-854", "Author": "Tsai CW, Hsu NY, Wang CH, Lu C, Chang Y, Tsai HH, Ruaan RC", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/19576903"}, {"Title": "Requirements for antibacterial and hemolytic activities in the bovine neutrophil derived 13-residue peptide indolicidin.", "Pubmed ID": "8849687", "Reference": "FEBS Lett. 1996;395:48-52", "Author": "Subbalakshmi C, Krishnakumari V, Nagaraj R, Sitaram N", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/8849687"}, {"Title": "Indolicidin analogs with broad-spectrum antimicrobial activity and low hemolytic activity", "Pubmed ID": "32593681", "Reference": "Peptides. 2020;132:170356", "Author": "Smirnova MP, Kolodkin NI, Kolobov AA, Afonin VG, Afonina IV, Stefanenko LI, Shpen VM, Shamova OV", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32593681"}], "Mass": 1712.09, "PI": 12.0, "Net Charge": 3, "Hydrophobicity": 0.35, "Frequent Amino Acids": "FPR", "Absent Amino Acids": "ACDEGHMNOQSTUVWY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 7, "Polar Residues": 6, "Positive Residues": 3, "Negative Residues": 0, "SPADE ID": "SPADE_UN_28005", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_22714", "Similarity": 1.0, "Sequence": "ILPFKFPFFPFRR"}, {"SPADE_ID": "SPADE_UN_22715", "Similarity": 1.0, "Sequence": "ILPFKFPFFPFRR"}, {"SPADE_ID": "SPADE_UN_28005", "Similarity": 1.0, "Sequence": "ILPFKFPFFPFRR"}], "Hemolytic Activity": "Human erythrocytes:6% Hemolysis=50 µM,Human erythrocytes:100% Hemolysis=125 µM,Human erythrocytes:50% Hemolysis=200 µg/ml", "Target Organism": "Bacillus subtilis IFO 3513(MIC=12.5µg/ml),Staphylococcus aureus IFO 12732(MIC=6.25µg/ml),Escherichia coli IFO 12734(MIC=100.0µg/ml),Micrococcus luteus ATCC 9341(MIC=0.4µM),Escherichia coli JM109(MIC=8µM),Escherichia coli W160-37(MIC=25-30µg/ml),Staphylococcus aureus ATCC 8530(MIC=2-4µg/ml),Saccharomyces cerevisiae PEP 4/3l(MIC=20-25µg/ml),Candida utilis CBS4511(MIC=20-25µg/ml),Escherichia coli ML-35p(MIC50=6±0.31µg/ml),Listeria monocytogenes EGD(MIC50=6.4±0.24µg/ml),Candida albicans 820(MIC50=49.9±0.62µg/ml)"}}}